Among the markers associated with tumor aggressiveness, an increase in vascular cell adhesion molecule (VCAM)-1 levels has been identified in patients with concurrent OSA and melanoma, when compared with patients with melanoma alone [94]. Here, VCAM1 is linked to melanoma.